Safety and Efficacy of Racotumomab-alum or Nimotuzumab versus Docetaxel as switch maintenance therapy for advanced non-small cell lung cancer patients: a Phase III open label randomized non-inferiority trial.
Hernandez M, Neninger E, Ortiz Ra, Santiesteban E, C. K, Amador Rm, Cala M, Bello L, Flores Y, Corella M, A. S, J. Y., Mendoza Ic, Viada C, Robaina M, Valenzuela C, Crombet T, Lage A
{"title":"Safety and Efficacy of Racotumomab-alum or Nimotuzumab versus Docetaxel as switch maintenance therapy for advanced non-small cell lung cancer patients: a Phase III open label randomized non-inferiority trial.","authors":"Hernandez M, Neninger E, Ortiz Ra, Santiesteban E, C. K, Amador Rm, Cala M, Bello L, Flores Y, Corella M, A. S, J. Y., Mendoza Ic, Viada C, Robaina M, Valenzuela C, Crombet T, Lage A","doi":"10.15761/gos.1000230","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":73175,"journal":{"name":"Global surgery (London)","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Global surgery (London)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15761/gos.1000230","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
